XLV ETF Analysis: Holdings, Fees, Inception, Sectors, And Portfolio Role

Investor Checklist

• Issuer and listing venue: State Street, NYSEARCA.
• Launch date and fee: Dec 16, 1998, 0.08%.
• Portfolio size and concentration: 63 holdings, with the top 10 at 59.75%.
• Primary exposure: Equity; Health; North America; Index: S&P Health Care Select Sector
• Best use case: Sector satellite position for investors who want targeted industry exposure instead of a broad-market fund.
• Main risk to respect: The key risk is that XLV's stated diversification may not protect investors if its dominant exposure, largest holdings, or main macro factor reverses. Current top-10 concentration is 59.75%.

XLV Investor Snapshot

XLV is State Street Health Care Select Sector SPDR ETF, issued by State Street. It is best understood as a satellite allocation for a specific industry view. The fund has $37.46B in AUM, charges 0.08%, holds 63 holdings, and has top-10 concentration of 59.75%. Its largest listed holdings include Eli Lilly and Company (14.86%), Johnson & Johnson (10.47%), AbbVie Inc. (7.02%).

XLV ETF Facts: Launch Date, Issuer, Fee, Assets, And Strategy

XLV is State Street Health Care Select Sector SPDR ETF. Issuer: State Street. Exchange: NYSEARCA. Inception: Dec 16, 1998. Expense ratio: 0.08%. AUM: $37.46B. Mandate or tracked index: S&P Health Care Select Sector

XLV Top Holdings And Concentration

Holdings snapshot: May 18, 2026. XLV has 63 holdings. The top 10 positions account for 59.75%, so investors should read the fund through its largest holdings first rather than assuming every ETF is equally diversified.

• $LLY - Eli Lilly and Company: 14.86%
• $JNJ - Johnson & Johnson: 10.47%
• $ABBV - AbbVie Inc.: 7.02%
• $UNH - UnitedHealth Group Incorporated: 6.72%
• $MRK - Merck & Co., Inc.: 5.30%
• $AMGN - Amgen Inc.: 3.31%
• $TMO - Thermo Fisher Scientific Inc.: 3.15%
• $GILD - Gilead Sciences, Inc.: 3.05%
• $ISRG - Intuitive Surgical, Inc.: 2.96%
• $ABT - Abbott Laboratories: 2.90%

XLV Sector And Industry Exposure

XLV exposure summary: Equity; Health; North America; Index: S&P Health Care Select Sector. These exposures explain what investors actually own after buying the ETF. A broad fund is usually driven by sector weights and mega-cap leadership; a sector or thematic fund is driven by the industry cycle; a bond or alternative asset fund is driven by macro variables rather than company earnings.

• Health Care: 99.87%. Sector weight from the latest public ETF holdings snapshot.
• Other: 0.13%. Sector weight from the latest public ETF holdings snapshot.
• United States: 100.00%. Country weight from the latest public ETF holdings snapshot.

XLV Fees, Liquidity, And Product Structure

XLV trades on NYSEARCA. The stated expense ratio is 0.08%, and current AUM is $37.46B. Lower fees matter most for long holding periods, while AUM and trading depth matter when investors place larger orders or need reliable execution during volatile sessions.

XLV Return Drivers: What Has To Go Right

The return drivers for XLV are industry earnings revisions, capital spending, valuation multiples, sector rotation, and the largest company weights. That matters because two ETFs can both look diversified but respond to very different conditions. For XLV, investors should compare price performance with the fund's dominant exposure, the largest holdings, and the macro factor behind the category.

XLV Current Market Theme

State Street Health Care Select Sector SPDR ETF is a Health ETF with $37.46B in AUM, 63 holdings, top-10 concentration of 59.75%, and a leading exposure to Health Care (99.87%). The largest holdings include Eli Lilly and Company (14.86%), Johnson & Johnson (10.47%), AbbVie Inc. (7.02%).

When XLV Tends To Work

XLV tends to work when industry earnings revisions, capital spending, valuation multiples, sector rotation, and the largest company weights are moving in the fund's favor.

XLV Portfolio Role: Core Holding Or Satellite Position?

Sector satellite position for investors who want targeted industry exposure instead of a broad-market fund. In practical portfolio terms, XLV should be sized according to whether it is replacing broad market exposure, adding a factor tilt, expressing a sector view, or hedging a macro risk. The more concentrated the fund, the less it should be treated as a complete portfolio by itself.

XLV Key Risks Investors Should Watch

The main risks are specific enough to check before buying, not generic ETF fine print.

• Market risk: XLV can fall with its asset class even when the fund structure works as designed.
• Concentration risk: top-10 weight is 59.75%, which is high for an ETF in this category.
• Exposure risk: the main exposure is Equity; Health; North America; Index: S&P Health Care Select Sector
• Fee and trading risk: expense ratio is 0.08%; investors should still check spread, volume, and premium/discount before large orders.
• Thesis risk: The key risk is that XLV's stated diversification may not protect investors if its dominant exposure, largest holdings, or main macro factor reverses. Current top-10 concentration is 59.75%.

Who XLV Is Suitable For

XLV can be useful, but the right investor depends on time horizon, existing overlap, and drawdown tolerance.

• More suitable for investors who need a satellite allocation for a specific industry view.
• More suitable for investors who understand that XLV's top holdings and sector exposures can dominate short-term returns.
• Less suitable for investors who need stable cash income unless the fund's underlying asset class is explicitly income-oriented.
• Less suitable for investors already heavily exposed to the same largest holdings or same macro factor.

XLV What To Monitor Next

XLV should be reviewed after new holdings files, major market moves, or category-specific catalysts. The most important checks are:

• Holdings as of May 18, 2026.
• AUM: $37.46B.
• Expense ratio: 0.08%.
• Top-10 weight: 59.75%.

XLV Action Reference

A useful ETF article should end with a decision framework. For XLV, the practical read is:

• Core-index investor: use as a satellite rather than a replacement for broad diversification.
• Theme investor: check whether the latest holdings still match the investment thesis.
• Risk-control investor: cap position size because sector/factor ETFs can underperform for long stretches.

XLV Bottom Line

XLV is not just a fund name. It is a package of exposures: State Street Health Care Select Sector SPDR ETF; issuer State Street; fee 0.08%; AUM $37.46B; 63 holdings; top-10 weight 59.75%; holdings date May 18, 2026. The investment case is strongest when the fund's largest holdings, main exposure, and category-level return drivers all point in the same direction.

Related Topics

Common Questions